PYPD
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- PolyPid regains European commercialization rights for D-PLEX100, expanding its global commercialization opportunitiesOct 1, 2026
- PolyPid receives FDA acceptance and Priority Review for D-PLEX100 NDAJul 29, 2026
- PolyPid signs an exclusive partnership with Azurity Pharmaceuticals to commercialize D-PLEX100 in the U.S. and CanadaJul 21, 2026
- PolyPid announced positive FDA pre-NDA meeting minutes supporting NDA submission for D-PLEX₁₀₀Dec 3, 2025
- PolyPid to present positive Phase 3 SHIELD II topline results at 2025 American College of Surgeons Clinical CongressSep 30, 2025